4.6 Article

The Stimulation of Macrophages with TLR Ligands Supports Increased IL-19 Expression in Inflammatory Bowel Disease Patients and in Colitis Models

Journal

JOURNAL OF IMMUNOLOGY
Volume 199, Issue 7, Pages 2570-2584

Publisher

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1700350

Keywords

-

Categories

Funding

  1. Swiss National Science Foundation [310030_146290]
  2. European Mucosal Immunology Group
  3. European Network of Immunology Institutes
  4. Swiss National Science Foundation (SNF) [310030_146290] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

IL-19, a member of the IL-10 cytokine family that signals through the IL-20 receptor type I (IL-20R alpha:IL-2012 beta), is a cytokine whose function is not completely known. In this article, we show that the expression of IL19 in biopsies of patients with active ulcerative colitis was increased compared with patients with quiescent ulcerative colitis and that colitis was attenuated in IL-19 deficient mice. The disruption of the epithelial barrier with dextran sodium sulfate leads to increased IL-19 expression. Attenuated colitis in IL-19 deficient animals was associated with reduced numbers of IL-6 producing macrophages in the inflamed colonic lamina propria. Microbial-driven expression of IL-19 by intestinal macrophages may contribute to the pathogenesis of inflammatory bowel disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available